Disrupting Skp2-cylin A interaction with a blocking peptide induces selective cancer cell killing

Molecular Cancer Therapeutics

Volumn 6, Issue 2, 2007, Pages 684-691

  Ji, Peng ^a,b   Sun, Daqian ^a   Wang, Hongbo ^a   Bauzon, Frederick ^a   Zhu, Liang ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN DEPENDENT KINASE 2; PEPTIDE; PROTEIN P27; S PHASE KINASE ASSOCIATED PROTEIN 2; TRANSCRIPTION FACTOR E2F1; CALCIUM BINDING PROTEIN; CIB1 PROTEIN, HUMAN; LOW DENSITY LIPOPROTEIN RECEPTOR; PEPTIDE FRAGMENT; S PHASE KINASE ASSOCIATED PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL KILLING; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FLUORESCENCE ACTIVATED CELL SORTING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN INTERACTION; WESTERN BLOTTING; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; PHYSIOLOGY;

BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CELL PROLIFERATION; CELL SURVIVAL; CYCLIN A; CYCLIN-DEPENDENT KINASE 2; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOPRECIPITATION; PEPTIDE FRAGMENTS; RECEPTORS, LDL; S-PHASE KINASE-ASSOCIATED PROTEINS; TUMOR CELLS, CULTURED;

EID: 33847387601     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-06-0538     Document Type: Article

References (20)

1. Zhang H, Kobayashi R, Galaktionov K, Beach D. p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell 1995;82: 915-25.
2. Bai C, Sen P, Hofmann K, et al. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 1996;86:263-74.
3. Cardozo T, Pagano M. The SCF ubiquitin ligase: insights into a molecular machine. Nat Rev Mol Cell Biol 2004;5:739-51.
4. 1-phase progression. Genes Dev 1999; 13:1501-12.
5. Nakayama K, Nagahama H, Minamishima YA, et al. Skp2-mediated degradation of p27 regulates progression into mitosis. Dev Cell 2004;6: 661-72.
6. Kossatz U, Dietrich N, Zander L, et al. Skp2-dependent degradation of p27kip1 is essential for cell cycle progression. Genes Dev 2004;18: 2602-7.
7. Hao B, Zheng N, Schulman BA, et al. Structural basis of the Cks1-dependent recognition of p27(Kip1) by the SCF(Skp2) ubiquitin ligase. Mol Cell 2005;20:9-19.
8. Lee SH, Mccormick F. Downregulation of Skp2 and p27/Kip1 synergistically induces apoptosis in T98G glioblastoma cells. J Mol Med 2005;83:296-307.
9. Kudo Y, Kitajima S, Ogawa I, et al. Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradation. Mol Cancer Ther 2005;4: 471-6.
10. Jiang F, Caraway NP, Li R, Katz RL. RNA silencing of S-phase kinase-interacting protein 2 inhibits proliferation and centrosome amplification in lung cancer cells. Oncogene 2005;24:3409-18.
11. Sumimoto H, Yamagata S, Shimizu A, et al. Gene therapy for human small-cell lung carcinoma by inactivation of Skp-2 with virally mediated RNA interference. Gene Ther 2005;12:95-100.
12. Ji P, Goldin L, Ren H, et al. Skp2 contains a novel cyclin A binding domain that directly protects cyclin A from inhibition by p27Kip1. J Biol Chem 2006;281:24058-69.
13. Sun D, Melegari M, Sridhar S, Rogler CE, Zhu L. A multi-miRNA hairpin method that improves gene knockdown efficiency and provides linked multi-gene knockdown. Biotechniques 2006;41:59-63.
14. Adams PD, Sellers WR, Sharma SK, et al. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol Cell Biol 1996;16:6623-33.
15. Castano E, Kleyner Y, Dynlacht BD. Dual cyclin-binding domains are required for p107 to function as a kinase inhibitor. Mol Cell Biol 1998;18: 5380-91.
16. Krek W, Ewen ME, Shirodkar SZ, et al. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 1994;78:161-72.
17. Krek W, Xu G, Livingston DM. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell 1995;83:1149-58.
18. Chen YN, Sharma SK, Ramsey TM, et al. Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists. Proc Natl Acad Sci U S A 1999;96:4325-9.
19. Tetsu O, Mccormick F. Proliferation of cancer cells despite CDK2 inhibition. Cancer Cell 2003;3:233-45.
20. Chen W, Lee J, Cho SY, Fine HA. Proteasome-mediated destruction of the cyclin A/cyclin-dependent kinase 2 complex suppresses tumor cell growth in vitro and in vivo. Cancer Res 2004;64:3949-57.